CDC panel backs full licensing of Pfizer-BioNTech COVID-19 vaccine

The Advisory Committee on Immunization Practices publicly reviewed data for the first time that supported Pfizer's COVID vaccine's full authorization.

     

from USATODAY - News Top Stories https://ift.tt/3BoGaoe